Radiomic Signatures To Predict Response To Targeted Therapy And Immune Checkpoint Blockade In Melanoma Patients (Pts) On Neoadjuvant Therapy.
Rivka R. Colen, Gabriel O. Ologun,Pascal Zinn,Murat Ak,Reetakshi Arora,Elizabeth M. Burton,Isabella Claudia Glitza,Hussein Abdul-Hassan Tawbi,Sapna Pradyuman Patel,Adi Diab,Michael K. Wong,Jennifer Leigh McQuade,Merrick I. Ross,Sara Ahmed,Nabil Elshafeey,Jeffrey E. Gershenwald,Michael A. Davies,Michael T. Tetzlaff,Rodabe Navroze Amaria,Jennifer Ann Wargo JOURNAL OF CLINICAL ONCOLOGY（2020）
AI 理解论文
溯源树
样例
